Sorrento Therapeutics, Inc. (SRNE)
OTCMKTS · Delayed Price · Currency is USD
0.0014
+0.0003 (27.27%)
Jul 9, 2026, 12:20 PM EST
Sorrento Therapeutics Market Cap
Sorrento Therapeutics has a market cap or net worth of $598.08 thousand as of July 9, 2026. Its market cap has decreased by -50.00% in one year.
Market Cap
598.08K
Enterprise Value
n/a
Revenue
64.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 24, 2009, Sorrento Therapeutics's market cap has decreased from 112.54M to 598.08K, a decrease of -99.47%. That is a compound annual growth rate of -26.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 8, 2026 | 598.08K | -57.69% |
| Dec 31, 2025 | 1.41M | 420.00% |
| Dec 31, 2024 | 271.86K | -99.60% |
| Dec 29, 2023 | 67.15M | -83.68% |
| Dec 30, 2022 | 411.38M | -71.18% |
| Dec 31, 2021 | 1.43B | -18.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avenue Therapeutics | 1.09M |
| Lyra Therapeutics | 1.06M |
| ZyVersa Therapeutics | 893.43K |
| Emmaus Life Sciences | 801.62K |
| Agentix | 801.34K |
| Halberd | 747.30K |
| Burzynski Research Institute | 719.02K |
| SQZ Biotechnologies Company | 707.79K |